These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 5818669)
1. Treatment of dysthyroid ophthalmopathy with local guanethidine. Cant JS; Lewis DR; Harrison MT Br J Ophthalmol; 1969 Apr; 53(4):233-8. PubMed ID: 5818669 [No Abstract] [Full Text] [Related]
2. Unwanted pharmacological effects of local guanethidine in the treatment of dysthyroid upper lid retraction. Cant JS; Lewis DR Br J Ophthalmol; 1969 Apr; 53(4):239-45. PubMed ID: 5818670 [No Abstract] [Full Text] [Related]
3. Dysthyroid eye disease. A trial of guanethidine eye drops. Bowden AN; Rose FC Br J Ophthalmol; 1969 Apr; 53(4):246-51. PubMed ID: 4889097 [No Abstract] [Full Text] [Related]
4. [Effect of guanethidine eyedrops on the ocular manifestations of Basedow's disease]. Berkman N; Joseph E Arch Ophtalmol Rev Gen Ophtalmol; 1971; 31(8):617-28. PubMed ID: 4256931 [No Abstract] [Full Text] [Related]
5. Critical study of 5 per cent guanethidine in ocular manifestations of Graves's disease. Cartlidge NE; Crombie AL; Anderson J; Hall R Br Med J; 1969 Dec; 4(5684):645-7. PubMed ID: 4902494 [TBL] [Abstract][Full Text] [Related]
6. [Action of 5 per cent guanethidine sulfate (ismeline) eye drops on lid retraction during Basedow's disease]. Storch J Ann Ocul (Paris); 1971 Jun; 204(6):627-44. PubMed ID: 5109312 [No Abstract] [Full Text] [Related]
7. [Ocular manifestations of Basedow's disease and local administration of guanethidine]. Berkman N; Joseph E Presse Med (1893); 1971 Jan; 79(3):83-6. PubMed ID: 5107433 [No Abstract] [Full Text] [Related]
8. Long-term trial of local guanethidine in treatment of eye signs of thyroid dysfunction and idiopathic lid retraction. Crombie AL; Lawson AA Br Med J; 1967 Dec; 4(5579):592-5. PubMed ID: 6060118 [No Abstract] [Full Text] [Related]
9. Effect of darkness on upper eyelid position. Neves LC; Cruz AA Ophthalmic Plast Reconstr Surg; 2005 Mar; 21(2):112-6. PubMed ID: 15778664 [TBL] [Abstract][Full Text] [Related]
10. Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy. Prummel MF; Wiersinga WM; Mourits MP; Koornneef L; Berghout A; van der Gaag R Arch Intern Med; 1990 May; 150(5):1098-101. PubMed ID: 1691908 [TBL] [Abstract][Full Text] [Related]
11. Adrenergic blockade and the eye signs of thyrotoxicosis. Sneddon JM; Turner P Lancet; 1966 Sep; 2(7462):525-7. PubMed ID: 4161643 [No Abstract] [Full Text] [Related]
12. [Clinical study on dysthyroid ophthalmopathy in Japanese. 1. Clinical approach to dysthyroid ophthalmopathy and definition]. Inoue Y; Inoue T Nippon Ganka Gakkai Zasshi; 1971 Jan; 75():929-40. PubMed ID: 5108269 [No Abstract] [Full Text] [Related]
13. [Clinical studies on dysthyroid ophthalmopathy in Japanese. 2. Classification of dysthyroid ophthalmopathy]. Inoue Y; Inoue T Nippon Ganka Gakkai Zasshi; 1971 Oct; 75(10):2057-62. PubMed ID: 5171780 [No Abstract] [Full Text] [Related]
15. Editorial: The eye signs of Graves disease. Lancet; 1974 Mar; 1(7856):491. PubMed ID: 4131889 [No Abstract] [Full Text] [Related]
16. Medical approach to ophthalmopathy of Graves' disease. Ivy HK Mayo Clin Proc; 1972 Dec; 47(12):980-5. PubMed ID: 4404646 [No Abstract] [Full Text] [Related]
18. [Retraction of the eyelids of endocrine origin treated with guanethidine (Ismelin) eyedrops]. Kjer P Ugeskr Laeger; 1968 Jan; 130(1):10-3. PubMed ID: 5694737 [No Abstract] [Full Text] [Related]
20. Use of guanethidine eye drops in dysthyroid lid retraction. Martin B; Jay B Proc R Soc Med; 1969 Jan; 62(1):18-9. PubMed ID: 5763459 [No Abstract] [Full Text] [Related] [Next] [New Search]